Deviations And Investigations-FDA Observations And How To Avoid Them
Website http://bit.ly/2gJFFxo |
Edit Freely
Category Pharmaceutical
Deadline: September 21, 2017 | Date: September 21, 2017
Venue/Country: Online Webinar, U.S.A
Updated: 2017-09-12 13:43:50 (GMT+9)
Call For Papers - CFP
Description:The GMPs require that the pharmaceutical firm complete and report an investigation of any product or process deviation or discrepancy and the FDA reviews investigations in depth in most site inspections. As a result, inadequate investigation is high on the list of FDA observations. Pharmaceutical firms either do not understand the expectation for, and value of, a thorough, timely investigation, or are not willing to commit the resources to appropriate investigations. In this webinar we will discuss the importance of and regulatory expectation for thorough, timely investigations and some of the tools that might be used during the investigation of a deviation.Speaker: Jerry LaneseOrganizer: Compliance Training PanelWebsite: http://bit.ly/2vECEny
Prize:239$/IndividualKeywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.